United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 249,376 | 137,524 | 174,560 | 204,874 | 142,189 |
| Depreciation Amortization | 24,726 | 12,434 | 48,361 | 35,984 | 24,123 |
| Income taxes - deferred | N/A | N/A | N/A | 105,659 | 67,165 |
| Accounts receivable | -86,473 | -5,913 | -10,027 | -15,244 | -15,455 |
| Accounts payable and accrued liabilities | 20,017 | 11,724 | 7,507 | 12,633 | 6,763 |
| Other Working Capital | -142,388 | 26,310 | -112,323 | -163,556 | -118,951 |
| Other Operating Activity | -9,141 | -71,482 | 317,189 | 140,496 | 75,712 |
| Operating Cash Flow | $56,117 | $110,597 | $425,267 | $320,846 | $181,546 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 265,069 | 125,055 | -232,298 | -89,358 | 77,050 |
| PPE Investments | -31,512 | -18,676 | -31,910 | -18,497 | -9,080 |
| Purchase Of Investment | -45,000 | N/A | -30,766 | -30,766 | -30,766 |
| Investing Cash Flow | $188,557 | $106,379 | $-294,974 | $-138,621 | $37,204 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 120,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | -1,320 | N/A | N/A |
| Common Stock Issued | 23,843 | 10,110 | 29,345 | 22,630 | 11,415 |
| Common Stock Repurchased | -377,562 | -97,633 | -42,439 | -42,438 | -42,438 |
| Other Financing Activity | -30,960 | 5,606 | 9,299 | 5,807 | 2,634 |
| Financing Cash Flow | $-264,679 | $-81,917 | $-5,115 | $-14,001 | $-28,389 |
| Exchange Rate Effect | 162 | -154 | -319 | -24 | -841 |
| Beginning Cash Position | 278,889 | 278,889 | 159,399 | 154,030 | 154,030 |
| End Cash Position | 259,046 | 413,794 | 284,258 | 322,230 | 343,550 |
| Net Cash Flow | $-19,843 | $134,905 | $124,859 | $168,200 | $189,520 |
| Free Cash Flow | |||||
| Operating Cash Flow | 56,117 | 110,597 | 425,267 | 320,846 | 181,546 |
| Capital Expenditure | -31,512 | -18,676 | -31,910 | -18,497 | -9,080 |
| Free Cash Flow | 24,605 | 91,921 | 393,357 | 302,349 | 172,466 |